Randomized prospective trial of cyclosporine with/without low-dose prednisolone in idiopathic membranous nephropathy in adults with nephrotic syndrome

Phase 4

Completed

• Conditions: idiopathic membranous nephropathy with nephrotic syndrome; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12609000996268
• Lead Sponsor: Research Group for Treatments of Kidney Diseases in Ibaraki, Japan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-03-31
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Biopsy proven idiopathic membranous nephropathy.

Over 3.5 g/day of excretion of urinary protein.

Exclusion Criteria

Secondary forms of membranous nephropathy.
Less than 70 ml/min of creatinine clearance.
Patients with relapse or recurrence.
Treated with other immunosuppressants.

Study & Design

• Study Type: Interventional
• Study Design: Not specified